These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7833131)

  • 21. Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
    Cascinu S; Alessandroni P; Rossi D; Del Ferro E; Fedeli A; Casadei V; Catalano G
    Cancer Chemother Pharmacol; 1996; 38(4):385-6. PubMed ID: 8674163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study.
    Punt CJ; de Mulder PH; Burghouts JT; Wagener DJ
    Cancer Chemother Pharmacol; 1992; 29(4):326-8. PubMed ID: 1537082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
    Di Costanzo F; Bartolucci R; Calabresi F; Sofra M; Marzola M; Belsanti V; Boni C; Bacchi M
    Ann Oncol; 1992 May; 3(5):371-6. PubMed ID: 1616890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
    Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
    Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
    Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a.
    Bernhard H; Klein O; Meyer zum Büschenfelde KH; Knuth A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):204-7. PubMed ID: 1557648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
    Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
    Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
    J Cancer Res Clin Oncol; 1998; 124(3-4):191-8. PubMed ID: 9619746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
    Di Costanzo F; Gasperoni S; Malacarne P; Belsanti V; Luppi G; Marzola M; Corgna E; Sdrobolini A; Passalacqua R; Figoli F; Algeri R; Zironi S; Angiona S; Boni C
    Am J Clin Oncol; 1998 Aug; 21(4):369-75. PubMed ID: 9708636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma.
    Knuth A; Bernhard H; Klein O; Meyer zum Büschenfelde KH
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):211-4. PubMed ID: 1557650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.
    Punt CJ; de Mulder PH; Burghouts JT; Wagener DJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):208-10. PubMed ID: 1557649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II study.
    Weh HJ; Platz D; Braumann D; Buggisch P; Schmiegel WH; Drescher S; Kleeberg UR; Müllerleile U; Crone-Münzebrock W; Hoffman R
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):180-4. PubMed ID: 1557644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    Ann Oncol; 1992 Jun; 3(6):489-91. PubMed ID: 1498068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.